Related Experiment Video
Updated: Jul 14, 2026

Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
Physiological and pathological properties of alpha-synuclein.
1Cambridge Centre for Brain Repair and Department of Clinical Neuroscience Forvie Site, Robinson Way, Cambridge CB2 2PY, United Kingdom.
Alpha-synuclein, a natively unfolded protein, can aggregate into harmful forms. This review explores its function and aggregation mechanisms in neurodegenerative diseases like Parkinson's.
Area of Science:
- Neuroscience
- Protein Biochemistry
- Molecular Biology
Background:
- Alpha-synuclein is a natively unfolded protein involved in lipid membrane interactions.
- Pathogenic conditions promote alpha-synuclein aggregation into amyloid fibrils.
- Familial Parkinson's disease is linked to alpha-synuclein gene mutations.
Purpose of the Study:
- To review the normal function of alpha-synuclein.
- To explore recent insights into alpha-synuclein aggregation mechanisms.
- To understand aggregation in sporadic neurodegenerative diseases.
Main Methods:
- Literature review of existing research.
- Analysis of protein structure and function.
- Examination of aggregation pathways.
Main Results:
- Alpha-synuclein adopts alpha-helical structures upon lipid binding.
- Aggregation involves a transition to beta-sheet configurations.
- Mechanisms in sporadic diseases remain incompletely understood.
Conclusions:
- Understanding alpha-synuclein aggregation is crucial for neurodegenerative disease research.
- Further investigation is needed for sporadic cases of Parkinson's disease, dementia with Lewy bodies, and multisystem atrophy.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Neural Regulation
Alzheimer Disease ll: Pathophysiology
Parkinson Disease l: Introduction

